Cigna Group Gestione

Gestione criteri di controllo 3/4

Cigna Group Il CEO è David Cordani, nominato in Jun2008, e ha un mandato di 16.42 anni. la retribuzione annua totale è $ 21.05M, composta da 7.1% di stipendio e 92.9% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.22% delle azioni della società, per un valore di € 186.69M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 4.2 anni e 5.9 anni.

Informazioni chiave

David Cordani

Amministratore delegato

US$21.0m

Compenso totale

Percentuale dello stipendio del CEO	7.1%
Mandato del CEO	16.4yrs
Proprietà del CEO	0.2%
Durata media del management	4.2yrs
Durata media del Consiglio di amministrazione	5.9yrs

Aggiornamenti recenti sulla gestione

Recent updates

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di David Cordani rispetto agli utili di Cigna Group?
Data	Compenso totale	Stipendio	Guadagni aziendali
Sep 30 2024	n/a	n/a	US$3b
Jun 30 2024	n/a	n/a	US$4b
Mar 31 2024	n/a	n/a	US$4b
Dec 31 2023	US$21m	US$2m	US$5b
Sep 30 2023	n/a	n/a	US$5b
Jun 30 2023	n/a	n/a	US$7b
Mar 31 2023	n/a	n/a	US$7b
Dec 31 2022	US$21m	US$2m	US$7b
Sep 30 2022	n/a	n/a	US$7b
Jun 30 2022	n/a	n/a	US$5b
Mar 31 2022	n/a	n/a	US$5b
Dec 31 2021	US$20m	US$2m	US$5b
Sep 30 2021	n/a	n/a	US$8b
Jun 30 2021	n/a	n/a	US$8b
Mar 31 2021	n/a	n/a	US$8b
Dec 31 2020	US$20m	US$2m	US$8b
Sep 30 2020	n/a	n/a	US$5b
Jun 30 2020	n/a	n/a	US$5b
Mar 31 2020	n/a	n/a	US$5b
Dec 31 2019	US$19m	US$2m	US$5b
Sep 30 2019	n/a	n/a	US$4b
Jun 30 2019	n/a	n/a	US$4b
Mar 31 2019	n/a	n/a	US$3b
Dec 31 2018	US$19m	US$1m	US$3b
Sep 30 2018	n/a	n/a	US$3b
Jun 30 2018	n/a	n/a	US$3b
Mar 31 2018	n/a	n/a	US$3b
Dec 31 2017	US$18m	US$1m	US$2b

Compensazione vs Mercato: La retribuzione totale di David ($USD 21.05M ) è superiore alla media delle aziende di dimensioni simili nel mercato German ($USD 4.83M ).

Compensazione vs guadagni: La retribuzione di David è stata coerente con le performance aziendali dell'ultimo anno.

AMMINISTRATORE DELEGATO

David Cordani (59 yo)

16.4yrs

Mandato

US$21,047,255

Compensazione

Mr. David Michael Cordani serves as Chair of the Board at The Cigna Group (formerly known as Cigna Corporation) since January 01, 2022. He has been the Chief Executive Officer and President of The Cigna Gr...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
David Cordani	President	16.4yrs	US$21.05m	0.22% € 186.7m
Brian Evanko	Executive VP	3.8yrs	US$7.79m	0.015% € 12.8m
Noelle Eder	Executive VP & Global Chief Information Officer	4.2yrs	US$5.27m	0.0061% € 5.2m
Nicole Jones	Executive VP	13.4yrs	US$5.21m	0.010% € 8.7m
Eric Palmer	Executive Vice President of Enterprise Strategy	less than a year	US$8.93m	0.020% € 17.1m
Jamie Kates	Chief Accounting Officer	less than a year	Nessun dato	0.00044% € 373.8k
Ralph Giacobbe	Senior VP & Head of Investor Relations	2.8yrs	Nessun dato	Nessun dato
Kari Stevens	Executive VP	no data	Nessun dato	Nessun dato
Jason Sadler	President of International MArkets & President of International Health Cigna Healthcare	10.4yrs	US$3.53m	0.015% € 12.4m
Christopher DeRosa	President of U.S. Government - Healthcare's Medicare & Individual & Family Plan (IFP) Businesses	1.4yrs	Nessun dato	Nessun dato
Phil Austin	Head of Strategy & Global Business Development for Cigna International Markets	4.7yrs	Nessun dato	Nessun dato
Dean Mirabella	President and GM of Florida & Caribbean Markets	11.2yrs	Nessun dato	Nessun dato

4.2yrs

Durata media

53yo

Età media

Gestione esperta: Il team dirigenziale di CGN è considerato esperto (durata media dell'incarico 4.2 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
David Cordani	President	15.1yrs	US$21.05m	0.22% € 186.7m
Donna Zarcone	Independent Director	19.8yrs	US$337.78k	0.0053% € 4.5m
Eric Foss	Independent Director	13.3yrs	US$335.28k	0.013% € 10.8m
Eric Wiseman	Lead Independent Director	17.6yrs	US$360.28k	0.0015% € 1.3m
Kimberly Ross	Independent Director	4.4yrs	US$337.78k	0.0014% € 1.2m
Kathleen Mazzarella	Independent Director	5.9yrs	US$335.28k	0.0020% € 1.7m
William DeLaney	Independent Director	5.9yrs	US$310.28k	0.0063% € 5.4m
Mark McClellan	Independent Director	5.9yrs	US$310.28k	0.0020% € 1.7m
Philip Ozuah	Independent Director	1.4yrs	US$248.50k	0.00042% € 356.8k
Elder Granger	Independent Director	5.9yrs	US$335.28k	Nessun dato
George Kurian	Independent Director	3.7yrs	US$310.28k	0.0011% € 959.9k
Neesha Hathi	Independent Director	3.2yrs	US$310.28k	0.00098% € 832.5k

5.9yrs

Durata media

62.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di CGN sono considerati esperti (durata media dell'incarico 5.9 anni).

Cigna Group Gestione

Gestione criteri di controllo 3/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Insufficient new directors

The Cigna Group, Annual General Meeting, Apr 24, 2024

the Cigna Group Announces Intention to Retire of Mary Agoglia Hoeltzel as Senior Vice President and Chief Accounting Officer, Effective from July 1, 2024

The Cigna Group Announces Management Changes

Cigna Healthcare Appoints Hisham Radwan as Chief Executive Officer of Cigna Insurance Saudi Arabia

Cigna Healthcare Appoints Hisham Radwan as Chief Executive Officer of Cigna Insurance Saudi Arabia

Recent updates

Biohealth Medical Laboratory, Inc. and PB Laboratories, LLC Provides an Legal Update

Biohealth Medical Laboratory, Inc. and PB Laboratories, LLC Provides an Legal Update

New major risk - Financial position

Third quarter 2024 earnings released: EPS: US$2.65 (vs US$4.79 in 3Q 2023)

Second quarter dividend of US$1.40 announced

Insufficient new directors

Cigna Healthcare Offers Medicare Customers Value, Stability and Choice with 2025 Plans

Upcoming dividend of US$1.40 per share

Second quarter 2024 earnings released: EPS: US$5.51 (vs US$4.96 in 2Q 2023)

First quarter dividend of US$1.40 announced

The Cigna Group Declares Quarterly Dividend, Payable on September 19, 2024

Upcoming dividend of US$1.40 per share

The Cigna Group to Report Q3, 2024 Results on Oct 31, 2024

First quarter 2024 earnings released: US$0.97 loss per share (vs US$4.29 profit in 1Q 2023)

Fourth quarter dividend of US$1.40 announced

The Cigna Group Declares Quarterly Dividend, Payable on June 20, 2024

National Center for Public Files an Exempt Solicitation Statement and Request Vote for the Proposal

The Cigna Group, Annual General Meeting, Apr 24, 2024

Full year 2023 earnings released: EPS: US$17.57 (vs US$21.66 in FY 2022)

Upcoming dividend of US$1.40 per share

Fourth quarter dividend of US$1.40 announced

Full year 2023 earnings released: EPS: US$17.61 (vs US$21.54 in FY 2022)

The Cigna Group Provides Earnings Guidance for the Fiscal Year 2024

The Cigna Group Declares Cash Quarterly Dividend, Payable on March 21, 2024

the Cigna Group Announces Intention to Retire of Mary Agoglia Hoeltzel as Senior Vice President and Chief Accounting Officer, Effective from July 1, 2024

The Cigna Group Announces Management Changes

Cigna Reportedly Ends Humana Merger Talks

Cigna, Humana Reportedly in Talks for Merger

Cigna Healthcare Appoints Hisham Radwan as Chief Executive Officer of Cigna Insurance Saudi Arabia

Cigna Healthcare Appoints Hisham Radwan as Chief Executive Officer of Cigna Insurance Saudi Arabia

Upcoming dividend of US$1.23 per share at 1.7% yield

The Cigna Group to Report Q2, 2024 Results on Aug 01, 2024

Cigna Reportedly Explores Shedding Medicare Advantage Business

Third quarter 2023 earnings released: EPS: US$4.79 (vs US$9.07 in 3Q 2022)

The Cigna Group Declares Quarterly Dividend, Payable on December 21, 2023

Cigna Healthcare Expands 2024 Medicare Advantage Plans Offering Customers More Variety and Value

The Cigna Group to Report Q1, 2024 Results on May 02, 2024

Cigna Healthcare Launches New Global Health Benefits Plan for Adults Aged 60+

Upcoming dividend of US$1.23 per share at 1.7% yield

Insider recently sold €2.1m worth of stock

Second quarter 2023 earnings released: EPS: US$4.96 (vs US$4.95 in 2Q 2022)

The Cigna Group Declares Quarterly Dividend, Payable on September 21, 2023

The Cigna Group Announces Executive Changes

Upcoming dividend of US$1.23 per share at 2.0% yield

First quarter 2023 earnings released: EPS: US$4.29 (vs US$3.76 in 1Q 2022)

Upcoming dividend of US$1.23 per share at 1.7% yield

Full year 2022 earnings released: EPS: US$21.54 (vs US$15.88 in FY 2021)

Cigna Corporation to Report Q3, 2023 Results on Nov 02, 2023

Cigna Corporation Declares Cash Dividend, Payable on March 23, 2023

Upcoming dividend of US$1.12 per share

Cigna Corporation to Report Q2, 2023 Results on Aug 03, 2023

Third quarter 2022 earnings released: EPS: US$9.07 (vs US$4.84 in 3Q 2021)

Cigna Corporation Declares Quarterly Dividend, Payable on December 21, 2022

Cigna Corporation to Report Q4, 2022 Results on Feb 03, 2023

Cigna Transforms Care Experience for Patients with Complex Conditions with Launch of Full Spectrum, Cost-Saving Products

BrainsWay Announces Significant Private Insurance Coverage from Cigna Corporation for the Treatment of OCD Utilizing Deep TMS

Cigna Corporation Appoints David Brailer as Executive Vice President and Chief Health Officer

Upcoming dividend of US$1.12 per share

Cigna Corporation Names Jerome Droesch as the Chief Executive Officer of Domestic Health and Health Services for All of Cigna International Markets Business Outside of the US

Second quarter 2022 earnings released: EPS: US$4.95 (vs US$4.30 in 2Q 2021)

Cigna Corporation Declares Quarterly Dividend, Payable on September 22, 2022

Chubb Life Insurance Company Ltd. acquired Life Insurance Operations of Cigna from Cigna Corporation (NYSE:CI).

Chubb Limited (NYSE:CB) acquired A&H and life business in Six Asia-Pacific Markets and Interest in Cigna Finans Emeklilik ve Hayat A.S. from Cigna Corporation (NYSE:CI) and Cigna Nederland Gamma B.V.

Upcoming dividend of US$1.12 per share

First quarter 2022 earnings released: EPS: US$3.71 (vs US$3.33 in 1Q 2021)

Cigna Corporation Declares Quarterly Dividend, Payable on June 23, 2022

Upcoming dividend of US$1.12 per share

Cigna Corporation Announces Executive Changes

Full year 2021 earnings: Revenues and EPS in line with analyst expectations